← Back to Search

Behavioural Intervention

Music-Based Relaxation for Anxiety in Young Cancer Survivors

N/A
Waitlist Available
Led By Robert Knoerl
Research Sponsored by University of Michigan Rogel Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years from start of study
Awards & highlights

Study Summary

This trial tested a 8-week program of relaxation music to reduce anxiety in young cancer survivors. Results showed it was effective.

Who is the study for?
This trial is for young cancer survivors aged 15-39 who have finished cancer treatment at least a month ago and are experiencing significant anxiety. Participants must be able to speak and read English, and they should score ≥55 on the PROMIS Anxiety 4a scale indicating notable anxiety levels.Check my eligibility
What is being tested?
The study is testing an eight-week virtual program called TiMBRe, which involves tailored music-based relaxation sessions lasting 45 minutes each week, aimed at reducing anxiety in adolescent and young adult cancer survivors.See study design
What are the potential side effects?
Since this intervention involves music-based relaxation techniques delivered virtually, there are no direct medical side effects expected. However, participants may experience varying degrees of emotional response to the relaxation exercises.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years from start of study
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years from start of study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of TiMBRe
Adherence to TiMBRe
Demand of TiMBRe
+1 more
Secondary outcome measures
Change in Anxiety management
Identification of facilitators and barriers to virtual TiMBRe participation

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TiMBReExperimental Treatment1 Intervention
an eight-week, (45 min/week), theory driven, virtually-delivered, tailored music-based relaxation (TiMBRe) intervention to decrease anxiety in AYA cancer survivors with clinically-relevant anxiety.
Group II: Attention-ControlActive Control1 Intervention
Standard of care study staff calls and cancer survivorship resources

Find a Location

Who is running the clinical trial?

University of Michigan Rogel Cancer CenterLead Sponsor
293 Previous Clinical Trials
24,067 Total Patients Enrolled
Robert KnoerlPrincipal InvestigatorUniversity of Michigan Rogel Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are octogenarians being enrolled in this investigation?

"As per the eligibility requirements of this clinical trial, 15 years old is the youngest age a participant can be while 39 is the oldest."

Answered by AI

Is the research currently seeking participants to join?

"According to the information found on clinicaltrials.gov, participation is no longer being sought for this particular research study which was initially posted June 1st 2023 and last updated on June 12th of that same year. Despite this trial having ended, there are 668 other studies actively recruiting participants at the time of writing."

Answered by AI

How can I enroll in this research experiment?

"This clinical trial seeks to recruit 30 participants of adolescent and young adult age with a diagnosis of anxiety. Qualified candidates should fall within the range of 15-39 years old."

Answered by AI
~20 spots leftby Jun 2028